Novartis files CAR-T therapy in Europe – PharmaTimes
PharmaTimes |
Novartis files CAR–T therapy in Europe
PharmaTimes Novartis has submitted an application to the European Medicines Agency for its CAR–T therapy CTL019 for two haematological indications. The drugs giant is seeking permission to market its cell therapy to treat children and young adults with relapsed or … |
